Drug Company Pays $4M For Using Fronts To Avoid Paying New Drug Fees To FDA

Mealey's (February 25, 2019, 1:32 PM EST) -- PHILADELPHIA — The U.S. attorney for the Eastern District of Pennsylvania announced Feb. 22 that drug company Lehigh Valley Technologies Inc. of Allentown, Pa., agreed to pay $4 million under the False Claims Act, 31 U.S. Code § 3729, to settle allegations that it used two front companies to avoid paying more than $2 million in prescription drug user fees....

Related Sections